Cite
Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial.
MLA
Ruijter, Bastian N., et al. “Tacrolimus 4‐hour Monitoring in Liver Transplant Patients Is Non‐inferior to Trough Monitoring: The Randomized Controlled FK04 Trial.” Clinical Transplantation, vol. 36, no. 12, Dec. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1111/ctr.14829.
APA
Ruijter, B. N., Tushuizen, M. E., Moes, D. J. A. R., Klerk, B. M. de, & Hoek, B. van. (2022). Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial. Clinical Transplantation, 36(12), 1–7. https://doi.org/10.1111/ctr.14829
Chicago
Ruijter, Bastian N., Maarten E. Tushuizen, Dirk J. A. R. Moes, Babs M. de Klerk, and Bart van Hoek. 2022. “Tacrolimus 4‐hour Monitoring in Liver Transplant Patients Is Non‐inferior to Trough Monitoring: The Randomized Controlled FK04 Trial.” Clinical Transplantation 36 (12): 1–7. doi:10.1111/ctr.14829.